financetom
Business
financetom
/
Business
/
BXP Expands Credit Facility, Raises Commercial Paper Program
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BXP Expands Credit Facility, Raises Commercial Paper Program
Mar 31, 2025 6:53 AM

09:22 AM EDT, 03/31/2025 (MT Newswires) -- BXP (BXP) said Monday it increased its unsecured revolving credit facility by $250 million to $2.25 billion and extended its maturity to March 2030.

The company said it also raised its unsecured commercial paper program by $250 million to $750 million and refinanced a $700 million term loan.

BXP said it extended the term loan for an initial four-year term, with two six-month extension options, subject to conditions.

The company fully drew on the loan at closing and used the proceeds to repay an existing $700 million unsecured term loan set to mature in May, BXP said.

As of March 28, $500 million was outstanding under the commercial paper program at a 4.66% weighted-average interest rate, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
South Korea signs agreement with AliExpress, Temu on product safety
South Korea signs agreement with AliExpress, Temu on product safety
May 13, 2024
SEOUL, May 13 (Reuters) - South Korea's government signed an agreement on Monday with the local units of Alibaba's ( BABA ) AliExpress and PDD Holdings' Temu to promote product safety, the Korea Fair Trade Commission (KFTC) said. The agreement comes after heightened regulatory scrutiny of AliExpress, Temu and other Chinese e-commerce platforms as they significantly expand their user base...
Regeneron Pharmaceuticals, Sanofi Say FDA Accepts Dupixent Supplemental Application for Priority Review
Regeneron Pharmaceuticals, Sanofi Say FDA Accepts Dupixent Supplemental Application for Priority Review
May 13, 2024
04:41 AM EDT, 05/13/2024 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) and Sanofi ( SNY ) said Monday the US Food and Drug Administration has accepted for priority review a supplemental biologics license application for Dupixent as an add-on maintenance treatment for adolescents aged 12 to 17 years with a type of sinus disease. The FDA is expected to...
Nvidia Providing Quantum Processing Chips for Supercomputers Worldwide
Nvidia Providing Quantum Processing Chips for Supercomputers Worldwide
May 13, 2024
04:09 AM EDT, 05/13/2024 (MT Newswires) -- Nvidia ( NVDA ) said Monday it will use its open-source CUDA-Q platform to power quantum processing units at national supercomputing centers in Germany, Japan and Poland. Germany's Julich Supercomputing Center is installing a quantum processing unit that uses Nvidia's ( NVDA ) GH200 Grace Hopper chip for chemical simulations and other uses....
Qiagen Receives FDA Clearance for Clinical Use of Respiratory Infection Test
Qiagen Receives FDA Clearance for Clinical Use of Respiratory Infection Test
May 13, 2024
04:18 AM EDT, 05/13/2024 (MT Newswires) -- Qiagen ( QGEN ) said Monday the US Food and Drug Administration has cleared its QIAstat-Dx Respiratory Panel Plus syndromic test for clinical use. The test is designed to help diagnose viral and bacterial upper respiratory infections. It was already granted FDA Emergency Use Authorization to detect the virus that causes COVID-19, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved